PEOPLE & PERSPECTIVE
About Us
Experienced leadership. International reach. Practical execution.
MEET OUR FOUNDER
Dr. Peter M. KovacsDr.Pharm., MSc., MBA, Ph.D.
Founder, PMK Ventures | Clinical Research Expert | Global Biotech & MedTech Strategic Advisor
Dr. Peter M. Kovacs is an internationally experienced clinical research executive, healthcare entrepreneur, and strategic advisor with more than 23 years of expertise in pharmaceutical development, clinical research, and the Biotech and MedTech industries.
Throughout his career, he has contributed to more than 350 clinical trials across multiple therapeutic areas and development phases, from early-stage research and first-in-human studies to advanced clinical development. He has founded and developed clinical research organizations, accredited Phase I clinical research units, and international research networks across Europe and Asia.
As the founder and CEO of PMK Group and CRU Global, Dr. Kovacs combines scientific knowledge, regulatory expertise, hands-on clinical execution experience, and strategic business insight. His professional background enables him to identify potential development challenges early, design efficient clinical strategies, minimize execution risks, and guide innovative healthcare companies toward clinical validation, commercialization, and successful exits.
Dr. Kovacs is a member of the National University of Singapore (NUS) Medicine International Council and is actively involved in international healthcare innovation ecosystems. He also serves as a mentor and judge for leading global and Asia-Pacific MedTech innovation initiatives, including MedTech Innovator, supporting emerging healthcare companies in their development and commercialization journeys.
His extensive international network connects pharmaceutical companies, clinical research organizations, academic institutions, key opinion leaders, healthcare innovators, and financial investors across Europe, Asia, and beyond.
Through PMK Ventures, Dr. Kovacs applies his accumulated knowledge, professional expertise, and global relationships to support promising Biotech and MedTech companies. Rather than providing direct financial investment, PMK Ventures focuses on strategic guidance, investor introductions, clinical development planning, and practical execution support, helping companies become more attractive to financial investors while reducing the risks associated with clinical development.
“Our most valuable contribution is not financial capital. It is the knowledge, experience, and global network that help innovative companies secure the right investment, execute their development plans, and turn promising science into successful healthcare businesses.”
— Dr. Peter M. Kovacs, Founder, PMK Ventures